29 results
424B5
OLMA
Olema Pharmaceuticals, Inc.
5 Jan 24
Prospectus supplement for primary offering
5:25pm
are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold
8-K
EX-10.1
qrf7h
5 Sep 23
Olema Oncology Announces Combined Financing for Up to $180 Million
7:39am
S-3
htbrjsaumnfusocokkf7
28 Feb 22
Shelf registration
6:34pm
10-Q
j6r0k8
11 May 21
Quarterly report
4:22pm
10-K
73365pj
17 Mar 21
Annual report
4:21pm